Show items per page
Elements: 112
Page 1 on 6
 TitleAuthors / EditorsDate
add to browser selection
A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Samaras, Nicolaos; Samaras, Dimitrios; Frangos Lordos, Emilia; Forster, Alexandre; Philippe, Jacques 2013
add to browser selection
Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes Herrera, Pedro Luis; Huarte, Joachim; Zufferey, R.; Nichols, A.; ... Vassalli, Jean-Dominique 1994
add to browser selection
Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy Tran, Christel; Philippe, Jacques; Ochsner, François; Kuntzer, Thierry; Truffert, André 2015
add to browser selection
Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 Schwitzgebel Luscher, Valérie; Mamin, Aline; Brun, Thierry; Ritz, Beate Andréa; ... Philippe, Jacques 2003
add to browser selection
Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinoma Philippe, Jacques; Sheybani, E.; Hirschel, Bernard; Ody, B. 1985
add to browser selection
An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events Hamer, Isabelle; Foti, Michelangelo; Emkey, R; Cordier-Bussat, M; ... Carpentier, J-L 2002
add to browser selection
Analogues du GLP-1 en 2019 : pour qui et comment ? Gariani, Karim; Philippe, Jacques 2019
add to browser selection
Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabétiques de type 2 obèses Marques, Ana Rita Forte; Jaafar, Jaafar; De Kalbermatten, Bénédicte Anne; Philippe, Jacques 2015
add to browser selection
Anti-CTLA-4 Monoclonal Antibodies Induced Hypophysitis: Case Report and Literature Review Jaafar, Jaafar; Philippe, Jacques 2017
add to browser selection
Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology Zanchi, Anne; Lehmann, Roger; Philippe, Jacques 2012
add to browser selection
Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis Gariani, Karim; Hugon, Justine; Philippe, Jacques; Righini, Marc Philip; Blondon, Marc 2019
add to browser selection
Association des analogues du GLP-1 et des inhibiteurs du SGLT2 : de nouvelles perspectives ? Ritz, Claire; Jaafar, Jaafar; Philippe, Jacques 2017
add to browser selection
Autonomous and self-sustained circadian oscillators displayed in human islet cells Pulimeno, Pamela; Mannic, Tiphaine; Sage, D; Giovannoni, Laurianne; ... Dibner, Charna 2013
add to browser selection
Baisse de la déhydroépiandrostérone avec l’âge : pertinence clinique et intérêt thérapeutique Samaras, Nikolaos; Samaras, Dimitrios; Forster, Alexandre; Frangos Lordos, Emilia; Philippe, Jacques 2015
add to browser selection
Biofeedback can reduce foot pressure to a safe level and without causing new at-risk zones in patients with diabetes and peripheral neuropathy De Leon Rodriguez, Diego; Allet, Lara; Golay, Alain; Philippe, Jacques; ... Pataky, Zoltan 2013
add to browser selection
Biological rhythms and preeclampsia Ditisheim, Agnès; Dibner, Charna; Philippe, Jacques; Pechere, Antoinette 2013
add to browser selection
Cellular circadian period length inversely correlates with HbA1c levels in individuals with type 2 diabetes Sinturel, Flore; Makhlouf, Anne-Marie; Meyer, Patrick; Tran, Christel; ... Dibner, Charna 2019
add to browser selection
Circadian clock characteristics are altered in human thyroid malignant nodules Mannic, Tiphaine; Meyer, Patrick; Triponez, Frédéric; Pusztaszeri, Marc; ... Dibner, Charna 2013
add to browser selection
Comment faire pour prévenir le diabète de type 2 en Suisse? Philippe, Jacques; Jornayvaz, François 2016
add to browser selection
Comment minimiser la prise de poids secondaire au traitement d'insuline? Philippe, Jacques 2010
<< previous | 1 | 2 | 3 | 4 | 5 | 6 |